The manufacturer of Tylenol products has found itself under
scrutiny for the second time this month.
Johnson & Johnson (
) has called back more Tylenol-based medications amidst complaints
from consumers about smells that are musty and moldy. Earlier this
month, the U.S. government announced plans to take over three
Tylenol plants that were operated by McNeil, which also
manufactures Motrin and Benadryl.
The most recent recall pertains to a surveillance effort. One lot,
which is 34,000 bottles, of Tylenol 8 Hour extended release caplets
is the focus of this recall. The Tylenol product in point was
manufactured in the Fort Washington, Pennsylvania plant before that
site was closed in April 2010.
Last year, McNeil called back in excess of 50 million bottles of
Tylenol, Motrin and Benadryl because of the same complaints about
moldy and musty odors. Trace amounts of a chemical called
2,4,6-tribromoanisole, which is used on wooden shipping pallets,
were to blame, according to company officials.
McNeil again pointed to the same cause as being responsible for the